SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of UnitedHealth Group Incorporated (UNH)

NEW YORK, Feb. 20, 2017

The investigation concerns whether UnitedHealth and certain of its officers and/or directors have violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934.

On February 16, 2017, a False Claims Act lawsuit against UnitedHealth was made public following the appeal of the U.S. Department of Justice. The complaint filed in 2011 under seal, alleges that UnitedHealth and other insurers had participated in a scheme to overcharge Medicare by "hundreds of millions — and likely billions — of dollars" for over a decade.  Following this news, UnitedHealth stock dropped $6.03 per share, or 3.68%, to close at $157.62 on February 17, 2017.

If you are aware of any facts relating to this investigation, or purchased shares of UnitedHealth, you can assist this investigation by visiting the firm's site: www.bgandg.com/unh. You can also contact Peretz Bronstein or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484. 

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique.  Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients.  In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration.   Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com